Literature DB >> 17713747

[Hypertension and cardiac failure].

C M Schannwell1, M G Hennersdorf, B E Strauer.   

Abstract

Arterial hypertension is the leading cause of mortality and morbidity with a worldwide prevalence of 26%. Aging increases the incidence of arterial hypertension. Arterial hypertension is the prime example for a chronic disease with asymptomatic beginning, creeping course and fatal outcome. Arterial hypertension is a major cardiovascular risk factor and leads to vascular as well as myocardial manifestations: coronary artery disease, hypertensive microvascular disease, concentric left ventricular hypertrophy as well as perivascular and interstitial fibrosis. In the late stages of the disease, hypertrophy and cardiac failure develop. Arterial hypertension is the leading cause of coronary artery disease and cardiac failure, and coronary artery disease is the cause of heart failure in 50% of cases. Various non-invasive and invasive procedures are available for screening and follow-up. The primary therapeutic target is to reverse cardiac manifestations of arterial hypertension using specific therapeutic algorithms as well as lowering blood pressure. This article covers the pathophysiology of arterial hypertension and cardiac failure, clinical symptoms, diagnostic options and therapeutical goals as well as medicinal options.

Entities:  

Mesh:

Year:  2007        PMID: 17713747     DOI: 10.1007/s00108-007-1913-y

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  47 in total

1.  1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee.

Authors: 
Journal:  J Hypertens       Date:  1999-02       Impact factor: 4.844

Review 2.  New insights and approaches to reduce end-organ damage in the treatment of hypertension: subsets of hypertension approach.

Authors:  M C Houston
Journal:  Am Heart J       Date:  1992-05       Impact factor: 4.749

3.  Change of left ventricular geometric pattern after 1 year of antihypertensive treatment: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.

Authors:  Kristian Wachtell; Björn Dahlöf; Jens Rokkedal; Vasilious Papademetriou; Markku S Nieminen; Gunnar Smith; Eva Gerdts; Kurt Boman; Jonathan N Bella; Richard B Devereux
Journal:  Am Heart J       Date:  2002-12       Impact factor: 4.749

Review 4.  New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment.

Authors:  Michael R Zile; Dirk L Brutsaert
Journal:  Circulation       Date:  2002-03-26       Impact factor: 29.690

Review 5.  [Cardiovascular end organ impairment due to hypertension].

Authors:  C M Schannwell; S Steiner; M G Hennersdorf; B E Strauer
Journal:  Internist (Berl)       Date:  2005-05       Impact factor: 0.743

6.  Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension.

Authors:  T Nishikimi; F Yoshihara; A Morimoto; K Ishikawa; T Ishimitsu; Y Saito; K Kangawa; H Matsuo; T Omae; H Matsuoka
Journal:  Hypertension       Date:  1996-07       Impact factor: 10.190

Review 7.  Left ventricular hypertrophy and coronary microcirculation in hypertensive heart disease.

Authors:  B E Strauer; B Schwartzkopff
Journal:  Blood Press Suppl       Date:  1997

Review 8.  Heart failure on the basis of hypertension.

Authors:  B Schwartzkopff; W Motz; M Vogt; B E Strauer
Journal:  Circulation       Date:  1993-05       Impact factor: 29.690

9.  Clinical evidence for an association between left ventricular geometric adaptation and extracardiac target organ damage in essential hypertension.

Authors:  Y Shigematsu; M Hamada; M Mukai; H Matsuoka; T Sumimoto; K Hiwada
Journal:  J Hypertens       Date:  1995-01       Impact factor: 4.844

10.  Influence of left ventricular geometric patterns on prognosis in patients with or without coronary artery disease.

Authors:  J K Ghali; Y Liao; R S Cooper
Journal:  J Am Coll Cardiol       Date:  1998-06       Impact factor: 24.094

View more
  1 in total

1.  Short‑term vagus nerve stimulation reduces myocardial apoptosis by downregulating microRNA‑205 in rats with chronic heart failure.

Authors:  Yanhua Xuan; Shuangshuang Liu; Yan Li; Jing Dong; Jiaying Luo; Tao Liu; Yuanzhe Jin; Zhijun Sun
Journal:  Mol Med Rep       Date:  2017-08-23       Impact factor: 2.952

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.